Medicare Part D copays are set to rise on branded drugs

11/21/2011 | Sioux City Journal (Iowa)

Out-of-pocket costs that Medicare Part D enrollees will pay next year for brand-name drugs will rise by an average of 40% for preferred drugs and 30% for nonpreferred drugs, according to an Avalere Health study. Copays for nonpreferred generic drugs will drop by about 43% and will stay about the same for preferred generics, the study found.

View Full Article in:

Sioux City Journal (Iowa)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations